To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intravenous and topical tranexamic acid have similar efficacy in TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2016

Intravenous and topical tranexamic acid have similar efficacy in TKA

Vol: 5| Issue: 2| Number:22| ISSN#: 2564-2537
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A

One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration.

Arch Orthop Trauma Surg. 2015 Apr;135(4):573-88.

Contributing Authors:
H Shemshaki SM Nourian N Nourian M Dehghani M Mokhtari F Mazoochian

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

31 randomized controlled trials were included in this meta-analysis which was conducted with the intention of comparing systemic (intravenous (IV)) and topical (intra-articular (IA)) administration of tranexamic acid (TXA). Outcomes of interest included total blood loss, rates of transfusion, and incidence of thromboembolic events. Upon analysis of the data, it was found that there was no signific...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue